QEP - QEP QEPリソ―シズ ()

QEPのニュース

   The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq  2021/03/18 12:16:32 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) BioAtla, Inc. (NASDAQ: BCAB ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Immatics N.V. (NASDAQ: IMTX ) ( announced positive Phase 1 readout for a trio of candidates in solid tumors) NGM Biopharmaceuticals, Inc. (NASDAQ: NGM ) NuVasive, Inc. (NASDAQ: NUVA ) Omnicell, Inc. (NASDAQ: OMCL ) Oncternal Therapeutics, Inc. (NASDAQ: ONCT ) Organogenesis Holdings Inc. (NASDAQ: ORGO ) PLx Pharma Inc. (NASDAQ: PLXP ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) STRATA Skin Sciences, Inc. (NASDAQ: SSKN ) Urovant Sciences Ltd. (NASDAQ: UROV ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 17) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) Galapagos NV (NASDAQ: GLPG ) Galecto, Inc. (NASDAQ: GLTO ) Stocks In Focus Translate Bio mRNA Product Candidate For Cystic Fibrosis Fails To Improve Lung Function In Phase 1/2 Study Translate Bio (NASDAQ: TBIO ) announced a second interim analysis from the Phase 1/2 study of MRT5005 in patients with cystic fibrosis, showing that repeat dosing was generally safe and well tolerated, with no serious adverse events.
   Diamondback Energy acquires rival QEP Resources  2021/03/17 20:35:22 Midland Reporter-Telegram
Diamondback Energy has completed its all-stock purchase of rival QEP Resources,…
   Diamondback Energy, Inc. Completes Acquisition of QEP Resources, Inc. | MarketScreener  2021/03/17 13:26:02 MarketScreener
MIDLAND, Texas, March 17, 2021 -- Diamondback Energy, Inc. today announced that it has completed its previously announced acquisition of QEP Resources, Inc. in an all-stock merger… | March 17, 2021
   Siebert Williams Shank & Co Stick to Their Hold Rating for QEP Resources By Investing.com  2021/03/15 09:08:21 Investing.com
Siebert Williams Shank & Co Stick to Their Hold Rating for QEP Resources
   ISS Reaffirms Recommendation FOR Pending Acquisition of QEP Resources by Diamondback Energy - Stocks News Feed  2021/03/11 22:50:06 Stocks News Feed
DENVER, March 11, 2021 (GLOBE NEWSWIRE) — QEP Resources, Inc. (NYSE:QEP) (QEP or the Company) today announced that Institutional Shareholder Services (ISS) has reaffirmed its previous recommendation of support for the proposed acquisition of QEP by Diamondback Energy, Inc. (NASDAQ:FANG) (Diamondback), citing the transaction’s “credible strategic rationale and multiple levers for value creation.” The proposed acquisition… Read More »ISS Reaffirms Recommendation FOR Pending Acquisition of QEP Resources by Diamondback Energy
   The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq  2021/03/18 12:16:32 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) BioAtla, Inc. (NASDAQ: BCAB ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Immatics N.V. (NASDAQ: IMTX ) ( announced positive Phase 1 readout for a trio of candidates in solid tumors) NGM Biopharmaceuticals, Inc. (NASDAQ: NGM ) NuVasive, Inc. (NASDAQ: NUVA ) Omnicell, Inc. (NASDAQ: OMCL ) Oncternal Therapeutics, Inc. (NASDAQ: ONCT ) Organogenesis Holdings Inc. (NASDAQ: ORGO ) PLx Pharma Inc. (NASDAQ: PLXP ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) STRATA Skin Sciences, Inc. (NASDAQ: SSKN ) Urovant Sciences Ltd. (NASDAQ: UROV ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 17) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) Galapagos NV (NASDAQ: GLPG ) Galecto, Inc. (NASDAQ: GLTO ) Stocks In Focus Translate Bio mRNA Product Candidate For Cystic Fibrosis Fails To Improve Lung Function In Phase 1/2 Study Translate Bio (NASDAQ: TBIO ) announced a second interim analysis from the Phase 1/2 study of MRT5005 in patients with cystic fibrosis, showing that repeat dosing was generally safe and well tolerated, with no serious adverse events.
   Diamondback Energy acquires rival QEP Resources  2021/03/17 20:35:22 Midland Reporter-Telegram
Diamondback Energy has completed its all-stock purchase of rival QEP Resources,…
   Diamondback Energy, Inc. Completes Acquisition of QEP Resources, Inc. | MarketScreener  2021/03/17 13:26:02 MarketScreener
MIDLAND, Texas, March 17, 2021 -- Diamondback Energy, Inc. today announced that it has completed its previously announced acquisition of QEP Resources, Inc. in an all-stock merger… | March 17, 2021
   Siebert Williams Shank & Co Stick to Their Hold Rating for QEP Resources By Investing.com  2021/03/15 09:08:21 Investing.com
Siebert Williams Shank & Co Stick to Their Hold Rating for QEP Resources
   ISS Reaffirms Recommendation FOR Pending Acquisition of QEP Resources by Diamondback Energy - Stocks News Feed  2021/03/11 22:50:06 Stocks News Feed
DENVER, March 11, 2021 (GLOBE NEWSWIRE) — QEP Resources, Inc. (NYSE:QEP) (QEP or the Company) today announced that Institutional Shareholder Services (ISS) has reaffirmed its previous recommendation of support for the proposed acquisition of QEP by Diamondback Energy, Inc. (NASDAQ:FANG) (Diamondback), citing the transaction’s “credible strategic rationale and multiple levers for value creation.” The proposed acquisition… Read More »ISS Reaffirms Recommendation FOR Pending Acquisition of QEP Resources by Diamondback Energy

calendar